Pragmatic approach may be the way forward for clinical trials By Paul McClure April 12, 2023 A new US clinical trial evaluating cancer treatment is adopting a pragmatic model, which lowers many of the ...
There is an explosion of innovation in drug development. In 2023, the FDA approved 55 novel drugs. There were five approved gene therapies for rare diseases, including the first-ever FDA-approved ...
2. Trial visits are kept to a minimum with potential utilization of telemedicine or stipends increase attendance 3. Trial mimics typical clinical workflow with minimization of visits, and laboratory ...
The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with ...
Gestational diabetes mellitus is common and is associated with an increased risk of adverse maternal and perinatal outcomes. Although experts recommend universal screening for gestational diabetes, ...
The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with ...
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary ...
Correspondence to Dr Eli Puterman, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada; eli.puterman{at}ubc.ca Background The number of adults across the globe with significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback